Overexpression of Ly6E promoted cancer cell growth and metastasis in gastric cancer (Lv et al., 2018), drug resistance and immune escape in breast cancer, and TGF-β-induced PD-L1 activation and binding of NK cells to cancer cells (AlHossiny et al., 2016). Here, LY6E is linked to breast carcinoma.